Researchers at the University of Illinois recently re-engineered small molecules to disrupt toxic RNA repeats involved in DM2.
News
July 22, 2014
Exciting news out of Washington, DC: the House of Representatives' Energy & Commerce Committee ordered the MD-CARE Act to advance to the House floor!
July 22, 2014
The DMCRN was established a little over a year ago to evaluate potential DM treatments, prepare possible clinical trial sites and conduct important DM research studies.
- 1 of 24
- next ›
